Curr Opin Microbiol. 2023 Apr 14;74:102319
The gut microbiota is now recognized to be a key driver of mucosal inflammation in inflammatory bowel disease (IBD). Robust functional and...
Gut. 2023 Jul;72(7):1296-1307
OBJECTIVE : The extent to which tryptophan (Trp) metabolism alterations explain or influence the outcome of inflammatory bowel diseases (IBDs) is still...
Clin Epigenetics. 2022 Nov 7;14(1):143.
When evolution leads to differences in body size, organs generally scale along. A well-known example of the tight relationship between...
Sci Rep 2022; 12: 8146
With the emergence of disease modifying osteoarthritis drugs (DMOAD), imaging methods to quantitatively demonstrate their efficacy and to monitor osteoarthritis...
Int J Mol Sci 2022; 23
Classical treatments of shoulder instability are associated with recurrence. To determine whether the modification of the capsule properties may be an alternative...
Front Immunol 2022; 13: 842538
Introduction : Osteoarthritis (OA) is a whole-joint disease characterized by a low-grade inflammation that is involved in both cartilage degradation and...
RMD Open 2022; 8
BACKGROUND : Considering non-classical environmental risk factors for osteoarthritis (OA), a systematic literature review (SLR) was performed to summarise existing...
Nanoscale 2022; 14: 8691-8708
The extracellular matrix (ECM) of articular cartilage is a three-dimensional network mainly constituted of entangled collagen fibrils and interfibrillar...
Sci Rep 2022 Vol. 12 Issue 1 Pages 1567
Osteoarthritis (OA) is a common disabling disease worldwide, with no effective and safe disease-modifying drugs (DMOAD) in the market. However,...
J Orthop Translat 2022; 32: 121-129
Osteoarthritis (OA) is a degenerative joint disease affecting millions of people worldwide. In OA, chondrocytes, synovial cells and other joint cells...